Delcath Systems to Host First Quarter 2023 Results
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Conference Call Information
To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call.
Event Date: Friday, May 12, 2023
Time: 8:30 AM Eastern Time
Participant Numbers: Toll Free: 1-833-630-1960
International: 1-412-317-1841
Webcast: https://app.webinar.net/EwPL2ydl3ra
CONFERENCE REPLAY | |
US Toll Free: | 1-877-344-7529 |
Canada Toll Free: | 855-669-9658 |
Replay Access Code: | 2940240 |
End Date: | May 19, 2023 |
About Delcath Systems, Inc.
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The Company's proprietary percutaneous hepatic perfusion (PHP) system is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In
In
Investor Relations Contact:
Ben Shamsian
Lytham Partners
646-829-9701
shamsian@lythampartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/delcath-systems-to-host-first-quarter-2023-results-301813980.html
SOURCE Delcath Systems, Inc.